WHO postpones evaluation of Russia’s Sputnik V coronavirus vaccine | CBC News


The World Well being Group mentioned Wednesday its analysis of Russia’s Sputnik V coronavirus vaccine has been postponed in the meanwhile, because of the “uneven scenario.”

WHO vaccines professional Dr. Mariangela Simao mentioned at a press briefing that the UN well being company’s officers had initially been scheduled to go to Russia on March 7 — simply weeks after Russia invaded Ukraine — to evaluate the amenities the place Sputnik V is produced.

“These inspections had been postponed for a later date,” Simao mentioned. “The evaluation, together with inspections, have been affected due to the scenario.

She defined that reserving flights had been tough and that there had been points with bank cards “and a few extra operational points.”

Western nations largely closed their airspace to Russian planes after Russia invaded Ukraine Feb. 24 and slapped wide-ranging sanctions on Russian monetary establishments.

“This has been mentioned with the Russian candidates, and new dates can be set as quickly as potential,” Simao mentioned.

Analysis has been underway since final yr

The WHO has been evaluating Russia’s Sputnik V vaccine for an emergency-use authorization since final yr. The authorization would permit Sputnik V to be bought as a part of the UN-backed COVAX effort to distribute vaccines worldwide and would lend credibility to a shot that some nations have been sluggish to take up.

A late-stage examine printed within the journal Lancet in 2020 involving greater than 20,000 contributors discovered that Sputnik V was protected and about 91 per cent efficient in opposition to an infection and extremely efficient at stopping folks from changing into severely unwell with COVID-19.

However final October, South Africa’s drug regulator rejected the shot, citing some security issues the Russian producer wasn’t in a position to reply. South African officers mentioned they had been involved that the expertise used within the Sputnik V shot won’t be protected in a inhabitants with excessive charges of HIV.

The European Medicines Company has mentioned its analysis of Sputnik V stays ongoing. The shot has been given the inexperienced gentle in additional than 70 nations. So far no vital security issues have been recognized.

Leave a Comment